Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CENPALAB (Centro Nacional para la Producción de Animales de Laboratorio) is a prominent Cuban scientific-productive complex and a key subsidiary of the BioCubaFarma group. Established in 1982, the center specializes in the breeding and supply of high-quality laboratory animals, including SPF (Specific Pathogen Free) and gnotobiotic models, which are essential for preclinical biomedical research. Beyond animal production, CENPALAB operates as a contract research organization (CRO) providing toxicology, pharmacology, and safety testing services. The center also manufactures biological products such as veterinary vaccines and diagnostic reagents under strict Good Manufacturing Practices (GMP). It serves as a critical infrastructure pillar for the Cuban biotechnology industry, supporting the development of both human and animal health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Center for the Production of Laboratory Animals.